AI Article Synopsis

  • Four triazole fungicides (fluconazole, myclobutanil, propiconazole, triadimefon) were tested for liver toxicity in mice, leading to liver cell growth (hypertrophy) and altered liver/body weight ratios, particularly at higher doses.
  • All triazoles induced specific liver enzymes (CYP) and affected the expression of various genes related to drug metabolism, suggesting potential differences in how each fungicide impacts liver health.
  • The study indicates that triazole-related liver damage may not only involve CYP enzyme induction but also other xenobiotic metabolizing enzymes influenced by certain nuclear receptors like CAR and PXR.

Article Abstract

Four triazole fungicides used in agricultural or pharmaceutical applications were examined for hepatotoxic effects in mouse liver. Besides organ weight, histopathology, and cytochrome P450 (CYP) enzyme induction, DNA microarrays were used to generate gene expression profiles and hypotheses on potential mechanisms of action for this class of chemicals. Adult male CD-1 mice were exposed daily for 14 days to fluconazole, myclobutanil, propiconazole, or triadimefon at three dose levels by oral gavage. Doses were based on previous studies that resulted in liver hypertrophy or hepatotoxicity. All four triazoles caused hepatocyte hypertrophy, and all except triadimefon increased relative liver/body weight ratios at the middle and high dose levels. CYP enzyme activities were also induced by all four triazoles at the middle and high doses as measured by the dealkylations of four alkoxyresorufins, although some differences in substrate specificity were observed. Consistent with this common histopathology and biochemistry, several CYP and xenobiotic metabolizing enzyme (XME) genes were differentially expressed in response to all four (Cyp2d26 and Cyp3a11), or three of the four (Cyp2c40, Cyp2c55, Ces2, Slco1a4) triazoles. Differential expression of numerous other CYP and XME genes discriminated between the various triazoles, consistent with differences in CYP enzyme activities, and indicative of possible differences in mechanisms of hepatotoxicity or dose response. Multiple isoforms of Cyp1a, 2b, 2c, 3a, and other CYP and XME genes regulated by the nuclear receptors constitutive androstane receptor (CAR) and pregnane X receptor (PXR) were differentially expressed following triazole exposure. Based on these results, we expanded on our original hypothesis that triazole hepatotoxicity was mediated by CYP induction, to include additional XME genes, many of which are modulated by CAR and PXR.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.taap.2006.02.016DOI Listing

Publication Analysis

Top Keywords

xme genes
16
cyp enzyme
12
gene expression
8
cd-1 mice
8
triazole fungicides
8
dose levels
8
middle high
8
enzyme activities
8
differentially expressed
8
cyp xme
8

Similar Publications

Genetic variants of antioxidant and xenobiotic metabolizing enzymes and their association with prostate cancer: A meta-analysis and functional in silico analysis.

Sci Total Environ

November 2023

GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Granada, Spain; University of Granada, Department of Biochemistry and Molecular Biology III and Immunology, Faculty of Medicine, PTS, Granada, Spain; Biosanitary Research Institute, ibs.GRANADA, Granada, Spain.

Article Synopsis
  • Prostate cancer (PCa) development is influenced by genetic, environmental, and dietary factors, particularly interactions between chemical exposures and specific genetic variants related to detoxification and DNA repair.
  • A meta-analysis involving over 60,000 participants identified significant associations between certain genetic variants (like SOD2, CAT, PON1, GSTP1, and GSTM1) and an increased risk of PCa, with GSTM1 showing the strongest link.
  • While antioxidant enzymes and detoxifying enzymes are crucial in PCa progression, other risk factors, especially chemical exposures, should also be considered for a comprehensive understanding of PCa risk.
View Article and Find Full Text PDF

Metabolic Activation of Benzo[]pyrene by Human Tissue Organoid Cultures.

Int J Mol Sci

December 2022

Department of Analytical, Environmental and Forensic Sciences, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9NH, UK.

Article Synopsis
  • Organoids are 3D cell cultures mimicking mammalian tissue, providing a more realistic environment for studying biological processes compared to traditional 2D cultures.
  • The study examined how human organoids from gastric, pancreas, liver, colon, and kidney tissues metabolize benzo[]pyrene (BaP), with gastric and colon organoids showing the highest susceptibility to its toxicity.
  • Results indicated that all organoid types could metabolize BaP, evidenced by the presence of specific metabolites and the activation of DNA damage response pathways, highlighting organoids' potential for research in environmental carcinogenesis and toxicology.
View Article and Find Full Text PDF

There is a need to characterize the potential susceptibility of older adults to toxicity from environmental chemical exposures. Liver xenobiotic metabolizing enzymes (XMEs) play important roles in detoxifying and eliminating xenobiotics. We examined global gene expression in the livers of young (21-45 years) and old (69+ years) men and women.

View Article and Find Full Text PDF

Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer.

Sci Total Environ

August 2020

GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Granada, Spain; University of Granada, Department of Biochemistry and Molecular Biology III, Faculty of Medicine, PTS, Granada, Spain.

Cancer is considered a complex disease that in many cases results from the interaction between chemical exposures, either from environmental or dietary sources, and genetic polymorphisms of xenobiotic-metabolizing enzymes (XME) or antioxidant enzymatic defenses. This study explored associations and interactions between genetic and environmental risk factors on the risk of prostate cancer (PCa) in 323 subjects that underwent prostate biopsy due to prostate specific antigen (PSA) levels above 4 ng/ml (161 PCa and 162 non-PCa). Eleven genes involved directly or indirectly in xenobiotic detoxification, oxidative stress and estrogen signaling were studied (GSTM1, GPX1 (rs1050450 and rs17650792), NAT2 (rs1801280), TXNRD1 (rs7310505), PRDX3 (rs3740562), CYP17A1 (rs743572), PON1 (rs662), SOD1 (rs10432782), SOD2 (rs4880), CAT (rs1001179), and ESR1 (rs746432)).

View Article and Find Full Text PDF

Xenobiotic-metabolizing enzymes (XME) mediate the body's response to potentially harmful compounds of exogenous/endogenous origin to which individuals are exposed during their lifetime. Aging adversely affects such responses, making the elderly more susceptible to toxics. Of note, XME genetic variability was found to impact the ability to cope with xenobiotics and, consequently, disease predisposition.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!